BESREMi (ropeginterferon alfa-2b) has emerged as a game-changing medication for people living with polycythemia vera (PV)—a uncommon blood condition where the body produces too many red blood cells. Making its debut in 2021, this long-acti…

IgG4-Related Disease (IgG4-RD) constitutes a rare, chronic autoimmune pathology characterized by IgG4-positive plasma cell infiltration across multiple organ systems, resulting in progressive fibrosis and functional impairment. This condit…

The PCSK9 Inhibitors Market has emerged as a critical therapeutic domain within cardiovascular medicine, delivering unprecedented treatment outcomes for patients with hypercholesterolemia who cannot achieve therapeutic lipid targets throug…